Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 58Squamous Cell Carcinoma of Head and Neck 37Nasopharyngeal Carcinoma 27Lung Neoplasms 25Uterine Cervical Neoplasms 22Biliary Tract Neoplasms 22Esophageal Squamous Cell Carcinoma 20Oropharyngeal Neoplasms 18Head and Neck Neoplasms 17Cholangiocarcinoma 17Urinary Bladder Neoplasms 14Neoplasms 14Neoplasm Metastasis 14Ovarian Neoplasms 13Esophageal Neoplasms 12Carcinoma 12Colorectal Neoplasms 11Stomach Neoplasms 10Small Cell Lung Carcinoma 10Carcinoma, Transitional Cell 8Mouth Neoplasms 7Laryngeal Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Squamous Cell 7Recurrence 6Nasopharyngeal Neoplasms 5Gallbladder Neoplasms 5Endometrial Neoplasms 5Breast Neoplasms 5Bile Duct Neoplasms 5

Interventions

Specimen Handling 2Biopsy 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1enfortumab vedotin 1durvalumab 1Vinblastine 1Platinum 1Nephroureterectomy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Renal Pelvis and Ureter Urothelial Carcinoma × Cisplatin × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡